# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Participants completed primary vaccination series (3 doses) with VLA15 Primary vaccination series to be followed by a booster a...
European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implication...
After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, P...
New funding will expand CytoReason's disease models and proprietary data, enabling R&D leaders at partner companies to ...
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain exper...